go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

Oregon rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $100,000 · 10th–90th $100,000$891,2510%50%90th$100,000Professionalmedian $489,779 · 10th–90th $489,779$691,8310%50%90th$489,779$0.1$1.0$20.0$500.0$10.0K$200.0K$5.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$977,237.22
Typical High
$1,174,897.55
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$630,957.34
Cigna
Setting
Professional
Modifier
Global
Typical Low
$467,735.14
Median
$489,778.82
Typical High
$588,843.66
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$169.82
Median
$489,778.82
Typical High
$1,023,292.99
Moda Health
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$537,031.80
Typical High
$933,254.30
Moda Health
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$524,807.46
Typical High
$758,577.58
Pacific Source
Setting
Facility
Modifier
Global
Typical Low
$100,000.00
Median
$100,000.00
Typical High
$100,000.00
Providence
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$537,031.80
Typical High
$891,250.94
Providence
Setting
Professional
Modifier
Global
Typical Low
$79.43
Median
$602,559.59
Typical High
$660,693.45
United
Setting
Facility
Modifier
Global
Typical Low
$1,000,000.00
Median
$1,000,000.00
Typical High
$1,000,000.00
United
Setting
Professional
Modifier
Global
Typical Low
$363,078.05
Median
$467,735.14
Typical High
$562,341.33